Telehealth & HOME ENROLLMENT with Zio

Remote cardiac monitoring is simple with Zio ECG monitors.

Zio ECG monitors fit into telehealth workflows easily, and ensures your patients can get access to care without an office visit.

How does it work?


How does it work?

Activate Home Enrollment today. 
Home Enrollment patient compliance and performance on par with in-clinic application
Devices applied
in clinic
Applied by
patients at home
Mean wear duration (days)
Median wear duration (days)
Mean analyzable time
Median analyzable time
Mean age
Median age
It's easy for your patients to apply a Zio ECG monitor at home.
Patient care at your fingertips with ZioSuite portal.

ZioSuite is an intuitive and comprehensive web portal and mobile app for healthcare professionals that enables remote care, and streamlines clinical workflows. You can:

  • Register patients remotely
  • Order monitors to be sent to patients for Home Enrollment
  • View and interpret patient reports from anywhere

Watch the overview.

Read how Spectrum Health is utilizing telehealth to create a new path forward for cardiovascular care of AFib patients in Cardiology.

Home Enrollment FAQs

A program that allows patients to receive and apply the Zio monitor at home, rather than the clinic.

  1. Eliminates patient exposure by reducing their visit to the clinic.
  2. Eliminates staff exposure to cleaning or re-using returned monitors that may have been exposed.
  3. Frees up staff resources to be used for response in other areas.
  4. Ensures patients who require ambulatory cardiac monitoring can continue to receive access to necessary monitoring.
  5. Zio monitors are all single-patient use. Patient contacting materials in the monitor are sourced from the US and final assembly is done in a US-based plant under controlled conditions.


Contact your local iRhythm representative or contact us.

Please allow 24 hours to process the Service Agreement; but often, it’s sooner.

No. iRhythm ships the monitors to patient’s home for them to self-apply. Post-wear, patients mail the device back to iRhythm using a pre-labelled box through USPS. You may track the device’s shipment and return status in ZioSuite.

In the Home Enrollment program, patients are sent the monitors for home application and clinics cannot bill for the hook up. Clinics can continue to bill for physician interpretation using CPT code: 93244 greater than 48 hours and up to 7 days, or 93248 for greater than 7 days up to 15 days.

No, iRhythm’s data show that turn-around time for the final report is on-par with our in-clinic service.

Clinics register patients via iRhythm’s patient management web portal ( or

iRhythm ships the monitor to a patient’s home; patients / caregivers apply the monitor themselves.

Once the clinic registers the patient on ZioSuite, iRhythm receives notification to ship the device to the patient. Patients will receive their monitors in 2-5 days after shipment. The device’s shipment and return status can be tracked in ZioSuite.

Yes. Instructions and support materials are included in each patient kit. Additionally, you may share this step-by-step instructional video with them.

Our expertly trained Customer Care team is available 24/7 for help at 888-693-2401.

Patients are also invited to join our Text Messaging program to receive helpful notifications and reminders during their monitoring period. Additionally, the MyZio app allows patients to track symptoms on their mobile phones and includes helpful content. Click here to learn more.

Yes, patient compliance rates remain high for Home Enrollment patients. Our data show that patients (age 65+) who self-applied the monitor had a mean-wear time of 12.1 days (vs. 12.5 days for in-clinic application), with 95.4% mean analyzable time (vs. 95.1% for in-clinic application).

For additional reference, in the recent mSToPS publication where all individuals self-applied the Zio monitor, the mean wear time per patch was 11.7 days, with 97.8% analyzable ECG data. (Steinhubl, S., et al. Effect of a Home-Based Wearable Continuous ECG Monitoring Patch on Detection of Undiagnosed Atrial Fibrillation: The mSToPS Randomized Clinical Trial. JAMA, 2018.)

Contact Us

We’re here for you.
Contact Customer Care 24/7